Citation Impact
Citing Papers
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
Specific Immune Induction Following DNA-Based Immunization Through In Vivo Transfection and Activation of Macrophages/Antigen-Presenting Cells
1998
Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model.
1998
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
DNA-Based Vaccine against La Crosse Virus: Protective Immune Response Mediated by Neutralizing Antibodies and CD4+ T Cells
1999
Vaccination for hepatitis C virus: closing in on an evasive target
2011
Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application
2002
Molecular mechanisms of HIV-1 associated neurodegeneration
2005
Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-γ, or IL-4 gene adjuvants
2001
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
The basis for HIV immunotherapeutic vaccines
2001
The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes
2001 StandoutNobel
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 StandoutNobel
Immunology of hepatitis B virus and hepatitis C virus infection
2005 Standout
Exposing the immunology of naked DNA vaccines
1995
Vaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus (HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCV
2000
Expression and Immune Response to Hepatitis C Virus Core Dna-Based Vaccine Constructs
1996
Mucosal immunity and vaccines
2005 Standout
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems
2004 StandoutNobel
Bacteria as DNA vaccine carriers for genetic immunization
2004
Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
2001 StandoutScience
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
1999 StandoutNobel
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
DNA vaccines for HIV: challenges and opportunities
2006
Controlled Delivery of Antigens and Adjuvants in Vaccine Development
1996
DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface
1999
The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine
1998
Transport of Nanoparticles Across the Rat Nasal Mucosa
2001
THE MOLECULAR BIOLOGY OF HEPATITIS C VIRUS
1999
Vaccination of Seronegative Volunteers with a Human Immunodeficiency Virus Type 1env/revDNA Vaccine Induces Antigen‐Specific Proliferation and Lymphocyte Production of β‐Chemokines
2000
New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview
1999
Presentation of SIVgag to monkey T cells using dendritic cells transfected with a recombinant adenovirus
2000 StandoutNobel
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
2000 Standout
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Protection against mycoplasma infection using expression-library immunization
1995 Nature
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice
1997
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA
1998 StandoutNobel
Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science
2001 Standout
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
1999
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Immune Recognition of Foreign DNA
1999
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Genetic Immunization of Mice Against Listeria monocytogenes Using Plasmid DNA Encoding Listeriolysin O
1999
Characterization of the Peptide Binding Motif of a Rhesus MHC Class I Molecule (Mamu-A*01) That Binds an Immunodominant CTL Epitope from Simian Immunodeficiency Virus
1998
Conserved CTL Epitopes Shared Between HIV-Infected Human Long-Term Survivors and Chimpanzees
1999
Genetic Immunization Generates Cellular and Humoral Immune Responses Against the Nonstructural Proteins of the Hepatitis C Virus in a Murine Model
1998
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Melioidosis: Epidemiology, Pathophysiology, and Management
2005 Standout
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Augmentation and Suppression of Immune Responses to an HIV-1 DNA Vaccine by Plasmid Cytokine/Ig Administration
1998
Progress in the Development of an HIV-1 Vaccine
1998 Science
Potentiation of Simian Immunodeficiency Virus (SIV)-Specific CD4+ and CD8+ T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen
2001
Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer
2000
Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen
2000
Antigen Presentation by Dendritic Cells after Immunization with DNA Encoding a Major Histocompatibility Complex Class II–restricted Viral Epitope
1997 StandoutNobel
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage ofMycobacterium tuberculosisHeat Shock Protein 70 Gene to an Antigen Gene
2001 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Expression of Noncovalent Hepatitis C Virus Envelope E1-E2 Complexes Is Not Required for the Induction of Antibodies with Neutralizing Properties following DNA Immunization
1999
Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus
1998
Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia
1999
ListeriaPathogenesis and Molecular Virulence Determinants
2001 Standout
Simian Immunodeficiency Virus (SIV)gagDNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Infection
2000
Comparison of Immunity Generated by Nucleic Acid-, MF59-, and ISCOM-Formulated Human Immunodeficiency Virus Type 1 Vaccines in Rhesus Macaques: Evidence for Viral Clearance
1999
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
Alphavirus-based expression vectors: strategies and applications.
1996 StandoutNobel
DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans.
1995
DNA Vaccines: Progress and Challenges
2005
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
2002 StandoutNobel
Interleukin 7 Can Enhance Antigen-Specific Cytotoxic-T-Lymphocyte and/or Th2-Type Immune Responses In Vivo
2000
DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector
1998
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture
2003 StandoutNobel
Cationic microparticles are a potent delivery system for a HCV DNA vaccine
2004 StandoutNobel
CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines.
1998
Reduction of Retrovirus-Induced Immunosuppression by In Vivo Modulation of T Cells during Acute Infection
2004 StandoutNobel
Molecular and Immunological Significance of Chimpanzee Major Histocompatibility Complex Haplotypes for Hepatitis C Virus Immune Response and Vaccination Studies
2002 StandoutNobel
Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti-Human Immunodeficiency Virus CD8+and CD4+T-Cell Responses from Chronically Infected Individuals
2001 StandoutNobel
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
Molecular Biology and Pathogenicity of Mycoplasmas
1998 Standout
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
DNA vaccination: antigen presentation and the induction of immunity
2000
Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA Vaccine
1998 Science
Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d
2003
DNA VACCINES
1997
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression
1998 StandoutNobel
Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination
1997
Dendritic Cells, Infected with Vesicular Stomatitis Virus-Pseudotyped HIV-1, Present Viral Antigens to CD4+ and CD8+ T Cells from HIV-1-Infected Individuals
2000 StandoutNobel
Micellization of block copolymers
2003 Standout
Dengue and Dengue Hemorrhagic Fever
1998 Standout
A sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expressionin vivo
1995
Potent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF
2002
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of Lori Gilbert being referenced
Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo
1994
DNA Inoculation Induces Neutralizing Immune Responses Against Human Immunodeficiency Virus Type 1 in Mice and Nonhuman Primates
1993
DNA Inoculation Induces Cross Clade Anti‐HIV‐1 Responses
1995
Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
1997
Induction of Humoral and Cellular Immune Responses to the Human Immunodeficiency Type 1 Virus in Nonhuman Primates by in Vivo DNA Inoculation
1995